Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
Ghana Pharmaceuticals and Healthcare Report Q1 2014

Ghana pharmaceuticals market marked the 10th anniversary of the country's national health insurance scheme in 2013


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2014-03-17 05:44:02 - Ghana Pharmaceuticals and Healthcare Report Q1 2014 - a new market research report on companiesandmarkets.com

Late 2013 saw Ghana mark the 10th anniversary of the creation of its national health insurance scheme (NHIS). While there are considerable variations in the claims made as to the number of people covered by the scheme (with government and non-government figures at either ends of the scale), there is no doubt that the scheme has had a degree of success. Not-for-profit Oxfam estimated in late 2013 that around 36% of the population has healthcare cover, thanks to the NHIS, but out of pocket payments for the rest (and invariably, poorer) segment of the population remain commonplace. Ghana is well placed in the continent to act as a regional drug production point, but in order to strengthen its reputation, it

 

 

must first crack down on counterfeit and substandard drugs. A batch of allegedly substandard anti-malarial drugs from Indian manufacturer Bliss GVS Pharma is a particularly prominent recent example of this. Ghana´s pharmaceutical and healthcare market has strong growth prospects, and over the course of our 10-year forecast period, we expect that non-communicable disease will place an increasing burden on the healthcare system.

Pharmaceuticals: GHC568mn (US$316mn) in 2012 to GHC708mn (US$346mn) in 2013; +21.0% in local currency terms and +9.3% in US dollar terms. Forecast upwardly revised from Q413.

Healthcare: GHC3.32bn (US$1.79bn) in 2012 to GHC3.77bn (US$1.84bn) in 2013; +13.6% in local currency terms and +2.7% in US dollar terms. Forecast braodly similar to Q413.

Risk/Reward Ratings: Ghana´s Pharmaceutical Risk/Reward Rating (RRR) score for Q114 is 38.0, making it the 20th most attractive market in the Middle East and African region.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com